Browse All

Current Filters

CLEAR FILTER x

TITLE

Treatment of PIRA with Nasal Foralumab Dampens Microglial Activation and Stabilizes Clinical Progression in Non-active Secondary Progressive MS

Treatment Outcomes and Healthcare Resource Utilization Among People Living with Focal Onset Epilepsy and Deemed to be Drug Resistant in Clinical Practices in the United States